NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 30 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 10 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
| Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
| Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
| UBS Group AG | 1,785 | $5,000 | 0.00% |